Genetic mosaicism manifests as spatially variable phenotypes, whose detection and interpretation remains challenging. This study identifies biological factors influencing spatial phenotypic patterns in the skeletons of somatic mutant zebrafish, and tests methods for their analysis using deep phenotyping. We explore characteristics of loss-offunction clusters in the skeleton of CRISPR-edited G0 ("crispant") zebrafish, and identify a distinctive size distribution shown to arise from clonal fragmentation and merger events. Using microCT-based phenomics, we describe diverse phenotypic manifestations in somatic mutants for genes implicated in monogenic (plod2 and bmp1a) and polygenic (wnt16) bone diseases, each showing convergence with germline mutant phenomes. Finally, we describe statistical frameworks for phenomic analysis which confers heightened sensitivity in discriminating somatic mutant populations, and quantifies spatial phenotypic variation. Our studies provide strategies for decoding spatially variable phenotypes which, paired with CRISPR-based screens, can identify genes contributing to skeletal disease.
INTRODUCTION
The past decade has seen a steady rise in genomics, fueled by advances in next-generation sequencing that have improved the speed and efficiency by which we can sequence genomes. Analogous to innovations in genome sequencing, advances in phenomics-i.e., in depth phenotyping at a large number of anatomical sites-can advance our understanding of how genetic variation influences phenotype, including biology that involves relationships between phenotypes across the whole organism (1) .
A particular example wherein phenomic profiling would lend such insight is in the context of genetic mosaicism: the presence of cells with multiple distinct genotypes constituting the organism on the whole. Mosaicism can arise naturally through errors in DNA replication, or intentionally through genetic manipulation. This genetic heterogeneity results in a hallmark of mosaicism-site-to-site phenotypic variability-which makes identifying gene-to-phenotype relationships challenging. In animal models, somatic mutations form the basis for rapid-throughput G0 screens, prototypes for which are rapidly increasing following the advent of CRISPR (Clustered-Regularly Interspaced spatial patterns among different somatic mutant groups. Robust phenomic workflows for somatic mutant analysis could help realize the full potential of CRISPR-based rapid throughput biology, and serve as a prototype to better understand clinical manifestations of mosaicism in human diseases (20, 21) .
Another source of difficulty is our limited understanding of biological factors that influence phenotypic expressivity in mosaic individuals. It is broadly accepted that spatial phenotypic patterns are dependent on the proliferation of mutant cells and their translocation to different sites. Lineage tracing of clonal populations from embryonic to adult zebrafish has provided a wealth of knowledge on clonal abundance in a variety of tissues, and suggests that, in most cases, a few clonal progenitors account for a majority of cells comprising the resulting tissue type (22) . Yet, how these clones distribute spatially within and across tissues remains unknown, and is a critical piece of information needed to interpret somatic mutant phenotypes. Spatial phenotypic patterns can also be influenced by the function of the mutated gene itself. For example, the degree to which phenotypic patterns mirror patterns of mosaicism likely depends on whether the gene acts cell autonomously or non-cell autonomously (20, 21) . While this implies that phenotypic patterns in mosaic individuals encode information related to gene function that is not present in germline mutants, instances of phenotypic pattern recognition in somatic mutant analysis are not well described.
Here, we identify patterns of mosaicism in the skeletons of CRISPR-edited somatic zebrafish, and relate these clonal distributions to phenotypes in mosaic models of brittle bone diseases. We employ a microCT-based workflow enabling profiling of hundreds of measures per fish (1) to characterize quantitative phenotypic variation, and perform experimentally-informed simulations to test methods for discerning and interpreting somatic mutant populations. Finally, we provide a case study for these methods by identifying and characterizing a novel zebrafish axial skeletal mutant whose target gene has been linked to genetic risk for osteoporosis.
RESULTS

CRISPR-based gene editing results in clusters of cells with loss-of-function
To examine patterns of loss-of-function in the skeleton, sp7:EGFP (23) embryos were injected with Cas9:guide RNA (gRNA) ribonucleoprotein complexes (RNPs) targeting the fluorescent transgene. This enabled loss-of-function mutations in EGFP to be visualized as loss-of-fluorescence in sp7+ (osterix+) osteoblasts. Fish injected with 10µM RNPs were examined for functional EGFP loss at 10-12dpf, a stage when the larvae are still transparent and many skeletal elements are present. Regions of loss-offluorescence were observed in virtually all formed skeletal elements ( Fig 1A) . This included bones of the craniofacial skeleton (opercle, interopercle, subopercle, dentary, pharyngeal arches, branchiostegal rays, cleithrum), median fin rays (ventral, caudal), hypurals, and the spine (neural and haemal arches, centra, Weberian apparatus). While penetrance of loss-of-fluorescence was high, expressivity was variable in regard to the composition of bony elements in each animal that exhibited regions of fluorescence loss, as well as the size and number of such regions within each bony element.
Loss-of-fluorescence regions are composed of clusters of cells with loss-offunction mutations: cells comprising each cluster represent a single clone, or multiple clones that merged at an earlier point in development (we are unable to distinguish these two possibilities). Within individual vertebrae, we often observed multiple, contiguous centra with complete or partial loss-of-fluorescence, and which were flanked by at least one centra with no loss-of-fluorescence. This resulted in two distinguishable types of cell clusters: "microscale" clusters confined within single vertebrae, and "macroscale" clusters spanning contiguous vertebrae ( Fig 1B) . Inspection at higher magnification revealed that some centra exhibited loss-of-fluorescence in ventral, but not dorsal, regions (or vice versa). This dorso-ventral stratification could at times be seen across contiguous centra ( Fig 1C) , potentially due to these bodies' shared clonal partners. In regard to the neural arches, loss-of-fluorescence often appeared to be associated with loss-of-fluorescence in the centrum of the same vertebral body ( Fig 1D) .
Because many bones retained partial or complete expression of the transgene, this suggested that, on the whole, individual bony elements are not explicitly derived from single clonal populations, and cannot be evaluated as independent functional or nonfunctional units.
A common distribution underlies the sizes of loss-of-function clusters in bones of distinct developmental lineages, and in animals with different mutation efficiencies
While some aspects of loss-of-fluorescence patterns appeared to be nonrandom, patterns from fish-to-fish were unpredictable, suggesting stochastic forces were an important etiological factor. Models of clonal population dynamics in fluorescencebased cell lineage tracing studies have demonstrated that while different factors can contribute to cluster size distributions during tissue growth, over time, contributions from random clonal merger and fragmentation (Fig 2A) become dominant over those from cell behaviors specified by developmental programs (e.g., cell division or loss)(24). As a consequence, cluster size distributions across diverse developmental processes often exhibit the same characteristic distribution once cluster sizes in each individual are normalized by the average cluster size in that individual (24). This distribution has the form:
where x is cluster size, and <x> is the mean of x (24).
Fluorescently-labeled cell clusters in cell lineage tracing studies and loss-offluorescence cell clusters in somatic mutants share commonalities in their physical origins (postzygotic mutations) and interpretation (clusters may be comprised of a single clonal population, or multiple clones that merged earlier in development). As such, we hypothesized that loss-of-function clusters in somatic animals would also exhibit universality in their size distributions described by Eq 1. To test this, we manually traced regions of complete loss-of-fluorescence (defined as a region with no detectable fluorescence above background, and/or markedly reduced signal compared to adjacent bony structures, see "Methods") on the dorsal and ventral aspects in the centra in each animal ( Fig 2B) . Regions confined to a single vertebrae were annotated as "microscale clusters"; regions spanning contiguous vertebrae were annotated as "macroscale clusters". Individual fish exhibited variable numbers and sizes of loss-of-function clusters ( Fig 2C) , as well as different compositions of microscale versus macroscale clusters.
This variability manifested as distinct distributions of loss-of-function cluster sizes in each fish ( Fig 2D) . However, when normalized by average cluster size in each animal, the cluster size distributions in each animal collapsed to the distribution in Eq 1 for both microscale and macroscale clusters ( Fig 2E) . We hypothesized that this distribution would also describe loss-of-function cluster sizes in bones of a different developmental lineage. We quantified loss-of-function cluster size distributions within the branchiostegal rays of the craniofacial skeleton, which unlike the somite-derived vertebral column, derives from neural crest (25). Consistent with our hypothesis, a similar data collapse was observed ( Fig 2F) . These studies demonstrate that loss-of-function cluster sizes in bones of distinct developmental lineages, and in animals with different loss-of-function efficiencies, can be described by a single distribution (Eq 1); the origin of which derives from numerical convergence behaviors associated with clonal fragmentation and merger events.
Somatic mutants for plod2 and bmp1a exhibit differences in variability in phenotypic expressivity
To better understand how mosaicism is phenotypically manifested in the skeleton, we generated somatic mutants for plod2 and bmp1a. In humans, mutations in PLOD2 and BMP1 are associated with Osteogenesis Imperfecta (OI), a heritable, heterogeneous group of connective tissue disorders commonly associated with skeletal deformities and bone fragility. OI is predominantly caused by dominant mutations in COL1A1 or COL1A2, whereas mutations in non-collagenous genes mostly cause autosomal recessive forms of OI (18); the latter genes include PLOD2 and BMP1 (26) .
The enzyme encoded by PLOD2, lysyl hydroxylase 2, localizes to the endoplasmic reticulum, and catalyzes lysine residue hydroxylation in fibrillar collagen telopeptides (27) . BMP1 is a secreted enzyme that functions in the cleavage of C-propeptides from procollagen precursors (28) . We and others previously showed that zebrafish germline loss-of-function mutants for plod2 and bmp1a exhibit severe skeletal abnormalities as adults, reminiscent of OI phenotypes (1, 27, 29, 30) .
Somatic mutants for plod2 and bmp1a were generated by injection of RNP complexes into embryos, and a subset of larvae were individually screened for indels at Further, 100% (11 out of 11) of animals were penetrant, as all individuals exhibited at least one severely malformed vertebra per animal. For bmp1a somatic mutants, most animals exhibited a qualitative increase in vertebral radiopacity and bone thickening. The extent of this increase was variable among individuals, ranging from mild to severe.
Variability in phenotypic expressivity within each animal was also evident in some cases. Certain plod2 somatic mutants exhibited "patchy" expressivity characterized by contiguous spans of one or more dysmorphic vertebrae surrounded by vertebrae that appeared qualitatively normal. This pattern was reminiscent of spatial characteristics of macroscopic loss-of-function clusters in sp7:EGFP fish previously characterized. In plod2 germline mutants, vertebrae are uniformly dysmorphic (27) , suggesting that such "patchy" expressivity is not an inherent property of plod2 loss of function in adult animals. In contrast to plod2, for bmp1a somatic mutants, intra-animal variability in phenotypic expressivity was less obvious; while radiopacity and thickening was variable from fish-to-fish, within each animal, these characteristics appeared to be relatively uniform. The relative uniformity in spatial expressivity in bmp1a crispants is discordant with the patchy mosaicism in osteoblasts of sp7:EGFP fish. Discordance between cell genotype and phenotype in mosaic animals suggets systemic/non-cell autonomous gene action. Consistent with this notion, the action of BMP1 is known to be non-cell autonomous, functioning as an extracellular enzyme involved in collagen processing. In contrast to the extracellular action of BMP1 in humans, the action of PLOD2 is intracellular as it modifies collagen in the endoplasmic reticulum.
MicroCT-based phenomics enhances sensitivity in discriminating somatic mutant phenotypes
To characterize phenotypes quantitatively, we performed microCT-based phenomics (1) . Recently, we developed a microCT-based workflow, FishCuT, which enables rapid (<5min/fish) quantification of 100s of measures in the axial skeleton of adult zebrafish (1, 18, 32 Fig 4B) . Differences in testing procedure were dependent on how loss-of-function regions were spatially clustered. For instance, for macroscale loss-of-function clusters ( Fig 4C) , analyzing Cent.Vol in vertebrae 1:16 with the global test conferred up to a 3.65-and 1.21-fold increase in sensitivity compared to analyzing vertebra 2 and the mean of vertebrae 1:16
with the M.-W. test, respectively; noticeably higher compared to simulations using microscale clusters ( Fig 4D) .
Notably, we found that the relative benefits of the global test, compared to the univariate tests, became heightened as mutants become increasingly mosaic (i.e., less germline mutant-like). Specifically, the sensitivity of the global test increased relative to the other tests with decreased values of lambda, the model parameter which parameterizes intra-animal variation ( Fig 4E) . While we did not explicitly vary characteristic effect size, we previously showed that the relative benefits of the global test, compared to t-tests, are highest as smallest effect size (1) . Finally, we performed non-parametric simulations using experimental data derived from plod2 somatic mutants show that the global test is an effective test for detecting differences in collections of spatially varying phenotypes in somatic mutants. Further, they provide evidence that deep phenotyping increases sensitivity, with similar specificity, in discriminating somatic mutant populations, compared to analyzing single readouts.
MicroCT-based phenomics can discriminate differences in spatial phenotypic variability
Spatial phenotypic variation in mosaic individuals has the potential to encode biological information. This is demonstrated by the high and low spatial variability seen in plod2 and bmp1a somatic mutants, respectively, which we speculate is due to differences in autonomy of gene action. Yet, consensus approaches to detect differences in spatial phenotypic variability are lacking. We explored the utility of Moran's I, a measure of global spatial autocorrelation commonly employed for geostatistical analysis, for this purpose. Moran's I usually ranges from approximately -1 to 1, and can be interpreted as the extent to which values are spatially clustered (positive), dispersed (negative), or random (zero) ( Fig 5A) . In Monte Carlo simulations, we found that microscale clusters resulted in Moran's I tending to decrease, whereas macroscale clusters resulted in Moran's I tending to increase ( Fig 5B) . For plod2 and bmp1a somatic mutants, when the distribution of Moran's I was calculated across all 10 combinatorial measures, there was a marked shift in the center of the distribution toward I=0 for plod2 somatic mutants compared to controls ( Fig 5C) . In contrast, no obvious shift in distribution center was observed for Moran's I in somatic mutants for bmp1a ( Fig 5D) , consistent with our qualitative observations. Thus, we conclude that Moran's I is an effective measure of spatial phenotypic variation, which may be useful for situations where qualitative observation of spatial variation is not possible. Moreover, because shifts in Moran's I in our simulations could be observed in the presence of relatively small effect sizes (e.g., 2-3x smaller than those in our study), our simulations suggest that Moran's I may be a useful metric to help discriminate differences in spatial variability for mutants with more subtle phenotypic effects. In Next, we assessed the extent to which somatic mutants for plod2 and bmp1a could act as faithful models of their germline mutant counterparts. For these analyses, we compared global test results to measurements and FishCuT outputs for plod2 and bmp1a germline mutants (n=3 for both germline groups) previously generated in (1) ( Fig   8) . Characteristic effect sizes in plod2 and bmp1a somatic mutants were, on average, 25.6% and 24.4%, respectively, of those in their germline mutant counterparts (plod2 somatic: 0.95; plod2 germline: 3.71; bmp1a somatic: 0.80; bmp1a germline: 3.23).
Occurrence of outliers (defined as absolute barcode values residing >1.5x the interquartile range (IQR) from the median (34)) were not appreciably different across somatic and germline mutant groups (plod2 somatic: 1.0%, plod2 germline: 7.3%;
bmp1a somatic: 1.1%, bmp1a germline: 0.6%).
Since the reduced standard length in plod2 somatic mutants was more muted compared to plod2 germline mutants (~4x less), we compared somatic mutant results to plod2 germline mutant phenotypes that had been subjected to allometric normalization.
We previously showed that by transforming WT sibling data to a 'virtual' phenome scaled to the mean standard length of age-matched mutants, allometric models provided a means to enable length-matched fish comparisons from an age-matched control group (1) . Across the 10 primary measures, somatic mutants for plod2 exhibited significant differences for 80% (4 out of 5) of the measures significantly altered in plod2 germline mutants ( Fig 8A,A' ). Moreover, 60% (3 out of 5) of the combinatorial measures not significantly different in plod2 mutants were also not different in plod2 somatic mutants.
Correspondence was noticeably lower when plod2 somatic mutants were compared to plod2 germline mutants that had not been allometrically normalized (3 of 6 corresponding measures with statistical significance, 50%; and 1 of 4 corresponding measures without statistical significance, 25%). Comparisons of results to the other 15 measures in FishCuT were not possible because allometric models have yet to be developed for them.
We also observed a high degree of correspondence between bmp1a somatic and germline mutant phenotypes ( Fig 8B,B' ). Specifically, across the 10 primary measures, bmp1a somatic mutants exhibited significant differences for 86% (6 out of 7)
of the measures significantly different in bmp1a germline mutants. Further, 67% (2 out of 3) of the measures not significantly different in bmp1a germline mutants were also not significantly different in bmp1a somatic mutants. Correspondence was not improved when comparing bmp1a somatic mutants to bmp1a germline mutants that had been subjected to allometric normalization. These studies suggest the potential for somatic mutants to predict germline mutant phenotypes with high fidelity.
Notably, for plod2 somatic mutants, mean vertebral traces appeared "smooth"despite intra-individual variability in phenotypic expressivity in some measures ( were reduced compared to those in germline mutants, due to the larger sample sizes in somatic mutant groups (plod2 somatic: n=11/group, plod2 germline: n=3/group; bmp1a somatic: n=15/group, bmp1a germline: n=3/group). In our Monte Carlo simulations, somatic mutants with characteristic effect sizes similar to those in plod2 and bmp1a somatic mutants were detected in the global test with >80% power (assuming alpha=0.05) using the sample sizes in our study. Taken together, somatic mutants can exhibit high correspondence with germline mutants, provided a sufficiently large sample, the size of which can be rationally estimated from simulations.
Somatic mutant analysis identifies skeletal phenotype following loss-of-function in wnt16
While the above studies suggested the benefits of deep skeletal phenotyping in increasing the fidelity of CRISPR-based G0 screens, one limitation is that they were performed in zebrafish models of monogenic bone disorders. We investigated consequences of loss-of-function in wnt16, a gene which has strong ties to genetic risk for osteoporosis in humans (35). In mice, loss of WNT16 affects both osteoclastogenesis (35) and bone formation (36, 37). WNT16 knockout in mice can result in low incidence of spontaneous fractures, depending on genetic background (38). However, in most mutants, bone appears grossly normal, with no trabecular loss, and moderate cortical thinning that can be resolved by microCT. Thus, we generated wnt16 somatic mutants in zebrafish to establish proof-of-concept that, by enhancing sensitivity in discerning somatic mutant phenotypes, G0 phenomic profiling may facilitate the detection of genes that are relevant to osteoporosis, a disease whose complex, multigenic nature has hampered the identification of causal variants and gene targets.
Somatic wnt16 mutants were generated in the same manner as those for bmp1a
and plod2. TIDE analysis revealed that wnt16 mutation efficiencies for individual 12dpf larvae ranged from 67.4% to 93.6% with a median efficiency of 80.1%. Mutational efficiency at this site was confirmed using next generation sequencing (NGS) ( Somatic mutant phenotypes for wnt16 were more subtle compared to those for plod2 and bmp1a. Characteristic effect sizes were reduced for somatic mutants for wnt16 compared to the other two genes (wnt16 somatic: 0.72; plod2 somatic: 0.95;
bmp1a somatic: 0.80). Moreover, wnt16 somatic mutants exhibited variability in body size and gross appearance that made robust phenotypic changes-specifically, those that were clearly independent of differences in developmental progress-difficult to discern by eye.
FishCuT analysis revealed a low bone mass phenotype in wnt16 somatic mutants. Somatic mutants for wnt16 exhibited significant changes in centrum volume (p=0.02) and centrum length (p=0.004) compared to sham injected clutchmates (n=12/group; Fig 10A) . Following allometric normalization, significant differences were observed for centrum TMD (p=0.0001), haemal arch TMD (p=0.0001), neural arch TMD (p=0.0002), and neural arch thickness (p=0.03) ( Fig 10-Supplemental Fig 1) . Because wnt16 somatic mutants did not exhibit normal allometry with standard length, this suggests that morphological differences in wnt16 somatic mutants were not solely due to developmental delay. Evaluation of morphological defects (rib fracture calluses, neural arch non-unions, centrum compressions, and centrum fusions) revealed no significant differences in the occurrence of a single defect type in wnt16 somatic mutants compared to controls. However, the proportion of animals exhibiting any such defect was significantly higher in wnt16 somatic mutants (p=0.01, n=12/group).
Wnts are secreted molecule that have been shown to exhibit long-range diffusion (39). Because of our studies in bmp1a somatic mutants suggesting that mutations in genes encoding for secreted factors result in lower spatial variability relative to those that whose actions are cell autonomous, we predicted that spatial phenotypic variability in wnt16 somatic mutants would be relatively low, and comparable with WT animals.
Consistent with this notion, when we examined the distribution of Moran's I in wnt16
somatic mutants, no obvious difference was observed compared to controls ( Finally, to determine if the somatic phenotype is representative of germline dysfunction in wnt16, we generated wnt16 F2 germline mutants harboring a frameshift allele (a 10 base pair insertion in exon 3) and subjected these fish to phenomic profiling (n=4 +/+, n=6 +/-, and n=6 -/-). Germline wnt16-/-mutants exhibited significant changes in centrum volume (p=0.002) and centrum length (p=7.1e-6) compared to +/+ clutchmates ( Fig 10B) . Heterozygous wnt16 germline mutants showed no significant changes compared to controls ( Fig 10-Supplemental Fig 3) , suggesting that the somatic wnt16 phenotype arises from mosaic bialleleic loss-of-function. Standard length was also significantly reduced in homozygous mutants (+/+: 17.4mm [15. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .9mm], -/-: 20.3mm
[18.9-20.8mm]; p=0.01; median [range]). No obvious differences in the frequency of centrum compressions and neural arch non-unions were observed between groups (although, germline mutant studies were underpowered to detect morphological defects).
Notably, the phenotype seen for wnt16 mutants was concentrated in the centrum (somatic and germline). In teleosts, centrum growth through the larval-to-adult transition has been attributed to osteoblasts originating in the intervertebral region (40).
These somatic wnt16 data, together with the germline correspondence for plod2
and bmp1a somatic mutants, support the fidelity of phenotyping directly in CRISPR- how these mutations manifest as phenotypic patterns, and how to quantitatively detect differences in these patterns within phenomic datasets, our studies help in decoding somatic mutant phenotypes using next generation phenotyping.
By visually depicting functional loss in sp7+ cells, we identified distinct characteristics in regard to how loss-of-function cell clusters in the skeleton distribute in space and size following CRISPR editing. We found that Eq 1, which was derived based on modeling of fluorescence-based lineage tracing studies, described loss-of-function cluster sizes in skeletal tissues derived from both the sclerotome (vertebrae), and neural crest (branchiostegal rays), and in animals with different levels of mutational loss-offunction. Because this relation arises via contributions from clonal fragmentation and merger events rather than cell fates specified by developmental programs, the data collapse in our study is unlikely to be unique to skeletal tissues, as clonal fragmentation and merger events initiate in the early developing embryo (24). While it remains to be seen whether a similar size distribution in loss-of-function clusters is observed in other tissues and organs, in lineage tracing studies, Eq 1 has been found to fit clonal cluster size distributions in diverse contexts including during development of the mouse and zebrafish heart, the mouse liver, and the mouse pancreas (24). Notably, this size distribution is not observed in developmental events where clonal fragmentation and merger events are suppressed (e.g., mouse acinar cells (24)), and we would expect while only the latter contributes to size distributions in loss-of-function clusters, both contribute to spatial distributions. Finally, because bone tissue accumulates throughout life, it is possible that spatial variations in somatic mutant skeletal phenotypes arise from evolving spatial patterns in mosaicism during growth. This can potentially be tested by visualizing patterns of CRISPR-induced lesions longitudinally. However, in vivo fluorescent imaging of the spine is difficult in adults, even in mutants that lack pigmentation, due to the scattering of light in deep tissue.
As a spatially distributed system comprised of repeating anatomical units, the spine is an excellent substrate for understanding how mosaicism manifests as spatial phenotypic patterns. We found that mutant phenotypes could be expressed relatively uniformly in the spine (bmp1a, wnt16), or in alternating patterns of affected and unaffected vertebrae (plod2). The relatively uniform phenotypic expressivity in bmp1a and wnt16 somatic mutants was discordant with the patchy loss-of-fluorescence patterns observed in sp7:EGFP fish. Indeed, phenotypic variability resembling a dosage curve has been previously hypothesized to occur when mutating a gene encoding a secreted factor, with different numbers of cells carrying the relevant mutation (42). Our studies suggest that somatic mutants can yield phenotypes for genes associated with cell autonomous or non-cell autonomous function, though the former may be associated with higher spatial variation. One practical implication is that for germline mutants caused by genes with unknown function, somatic mutants may be intentionally created, and screened for spatial phenotypic variability, as a means to inform autonomy in gene action.
Statistical methods to decode somatic mutant phenotypes are lacking. We found that the global test was an effective test in discriminating collections of spatially variable phenotypes. The increased sensitivity of analyzing vertebral patterns with the global test, relative to univariate approaches, underscore the potential for deep phenotyping to improve G0 screen productivity, and facilitate the study of genetic variants of smaller effect sizes. Notably, the global test can be used for multivariate phenotypes where spatial relationships are not specified (e.g., a panel of measures taken at the same anatomical site), and thus may be broadly useful for detecting differences in groups of measures between different populations. We also found that Moran's I was sensitive to spatial phenotypic variation, suggesting that it could be employed in other G0 screens to Familial cases for PFFD have been described (45) . By showing differences in Moran's I between plod2 somatic mutants and controls, our studies suggest the potential for deep phenotyping, in concert with spatial statistical analysis, to help distinguish phenotypic variation that naturally occurs within individuals, from that associated with mosaicism.
Human genome-wide association studies have identified over 200 loci (46, 47) associated with BMD and fracture risk in humans, however, most of the causal genes responsible for these associations have yet to be definitively assigned. Large-scale screens of candidate genes provide a mechanism to attribute functional skeletal contributions of these genes to osteoporosis-related traits. We identified a bone mass phenotype in zebrafish somatic and germline mutants for wnt16. Because this gene is implicated in mediating inter-individual variation in BMD and fracture risk in humans (48, 49) , this broadens our understanding of zebrafish mutant phenotypes that may be predictive of human BMD and fracture risk. Somatic wnt16 mutants successfully recapitulated phenotypic signatures in germline wnt16 mutants, providing further evidence of the fidelity of phenotyping directly in CRISPR-edited G0 somatic mutants.
While throughput of our workflow is limited by the time required for microCT acquisition (~5min/fish when 8 fish are scanned simultaneously (1)), this can potentially be overcome advances in high-throughput microCT (1) . Though it remains to be seen if faithful correlation between somatic and germline mutant phenotypes exists for most skeletal genes, microCT-based phenomics, in concert with CRISPR-based G0 screens, is a promising direction for the rapid identification of candidate genes and development of targeted therapies for mono-and multigenic skeletal diseases.
In conclusion, our studies advance our understanding of how somatic mutations disseminate during development, how these mutations manifest as phenotypic patterns, and how to quantitatively detect differences in these patterns within phenomic datasets.
In doing so, our studies help in using next generation phenotyping to decode somatic mutant phenotypes, which may confer advantages and additional insights in both experimental and clinical contexts.
MATERIALS AND METHODS
For more detailed methods, see SI Appendix.
Zebrafish rearing
All studies were performed on an approved protocol in accordance with the University of Washington Institutional Animal Care and Use Committee (IACUC). Studies were conducted in mixed sex animals from either the wild-type AB strain or the transgenic sp7:EGFP (23) background. A description of plod2 and bmp1a germline strains used for comparative analysis is described in (1).
CRISPR-induced mutagenesis
CRISPR mutagenesis was performed using the Alt-R TM CRISPR-Cas9 System from Integrated DNA Technologies (IDT). For each gene, gRNAs were generated by mixing the crRNA and tracrRNA in a 1:1 ratio, diluting to 20 µM in nuclease-free duplex buffer (IDT), incubating at 95 o C for 5 minutes and cooling on ice. Cas9 protein (20 µM, NEB) was mixed in a 1:1 ratio with the gRNA complex and incubated for 5-10 minutes at room temperate to produce the Cas9:gRNA RNP complex at a final concentration of 10 µM. RNPs were loaded into pre-pulled microcapillary needles (Tritech Research), calibrated, and 2 nL RNP complexes were injected into the yolk of 1-to 4-cell stage embryos.
Sequencing and mutation efficiency analysis
Between 24 and 96 hpf, a few embryos from each injection group were pooled, DNA extracted, Sanger sequenced (GenScript), and screened for editing efficiency using the TIDE webtool (50) . Individual animals were also screened for mutagenesis using whole larvae at 12 dpf to predict editing efficiencies using the TIDE webtool, and to check for clonal fitness effects. These data are reported as intra-animal efficiencies in the main text. For next generation sequencing, a single wnt16 sample was prepared according to the recommended guidelines for CRISPR amplicon sequencing at the MGH CCIB DNA Core affiliated with Harvard University. High-quality reads were aligned, identical and similar sequences (those with isolated SNPs not affecting indels were considered similar) were collapsed, and counts of unique alleles with more than 10 paired reads are reported.
MicroCT scanning and image analysis
MicroCT scanning was performed using a vivaCT40 (Scanco Medical, Switzerland) with 21 µm isotropic voxel resolution, and analyzed using FishCuT software (1, 32) . Notably, Eq 1 is expected to hold for clones representing mono-or multi-allelic loss, and thus our use of animals with mixed transgenic zygosities is not expected to influence our results. G0 crispants used for assessment of clonal dynamics were excluded if no distinct fluorescence could be detected above background during imaging. No attempt was made to quantify relative levels of fluorescence within or between fish. Further, loss of fluorescence (due to gene editing of either one copy or multiple copies of the transgene) was defined as complete loss of fluorescence (i.e. signal was indistinguishable from background).
Monte Carlo simulations
We previously characterized multivariate distributions for select FishCuT measures that exhibit evidence of multivariate normality (1) . Using parameter estimates previously derived for such measures, we constructed wildtype and mutant distributions using methods described in Supplemental 
Statistical analysis
In general, the Mann-Whitney test was used for univariate analyses between two groups. Dysmorphic phenotypes were analyzed using a test for equal proportions.
Multivariate analysis was performed using the global test. p<0.05 was considered statistically significant in all cases. plod2 germline mutant bmp1a germline mutant Fig 8-Supplemental Fig 1. Somatic mutants for bmp1a and plod2 exhibit inter-and intra-animal phenotypic variability that becomes averaged out across the sample. 
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